Schrödinger stock skyrockets as Novartis invests billions in new partnership
In a landmark development, Schrödinger, Inc. has entered into a multi-target research collaboration and expanded software licensing agreement with Novartis AG, potentially valued at up ... Read More
Centene’s biggest stock drop in years—what’s behind the plunge?
Centene Corporation’s shares experienced their steepest decline in four years, plunging by 7.7% after news of a renewed contract for its subsidiary, Iowa Total Care, ... Read More
Sun Pharma introduces STARIZO to tackle drug-resistant skin infections in India
Sun Pharmaceutical Industries Limited has introduced STARIZO (Tedizolid Phosphate) to the Indian market, a novel antibacterial treatment targeting Acute Bacterial Skin and Skin Structure Infections ... Read More
Lupin Limited secures major victory: A perfect FDA score for its Gujarat plant
Lupin Limited (Lupin), a global pharmaceutical powerhouse, has been awarded the Establishment Inspection Report (EIR) by the United States Food and Drug Administration (U.S. FDA). ... Read More
Strides Pharma Science gets FDA approval for Fluoxetine Tablets for depressive disorders
Strides Pharma Science Limited (Strides) has made a notable advancement in the field of mental health treatment by securing approval from the United States Food ... Read More
Sanofi India partners with Cipla Limited for enhanced distribution of CNS product range
In a strategic move poised to reshape the landscape of Central Nervous System (CNS) medication accessibility in India, Sanofi India Limited (SIL) and Cipla Limited ... Read More
Gilead Sciences completes $4.3bn acquisition of CymaBay Therapeutics to enhance liver disease portfolio
Gilead Sciences, Inc. (Nasdaq: GILD) has officially announced the successful acquisition of CymaBay Therapeutics, Inc. (Nasdaq: CBAY) for a staggering $4.3 billion, a move that ... Read More
Aurobindo Pharma gains FDA approval for Mometasone Furoate Monohydrate Nasal Spray
In a major development within the pharmaceutical industry, Aurobindo Pharma Limited (Aurobindo) announced it has received final approval from the US Food & Drug Administration ... Read More
Eisai invests $15m in C₂N Diagnostics to advance Alzheimer’s disease diagnostics
In a significant move for the field of brain health diagnostics, C₂N Diagnostics, LLC, a pioneer in developing advanced diagnostic solutions for Alzheimer's disease, has ... Read More
Zydus Lifesciences announces Punit Patel as new CEO for Americas operations
Global lifesciences firm, Zydus Lifesciences Limited, recently declared the appointment of Punit Patel as the President and Chief Executive Officer for its Americas wing. He's ... Read More